Studies carried out on an animal model confirm the mutual synergy of action between oestradiol and leptin in the aetiology of endometrial cancer development, which is manifested by transactivation of the Ob-R receptor through mutual activation of the JAK-STAT pathway [105], and this is presented in Figure 2. This evidence concerns the gene LEP and endometrial cancer.